IPO registrations (S-1, F-1) · Registrants

Spark Therapeutics, Inc.

SEC CIK
1609351 · filings on EDGAR ↗
Registration
Form S-1, first filed 2014-12-30, last 2015-12-14; 2 initial registrations, 3 amendments
Outcome
Final prospectus filed 2015-01-30; declared effective 2015-01-29
Industry (SIC)
Biological Products, (No Diagnostic Substances) 2836
Incorporated in
DE
Business address
3737 MARKET STREET, SUITE 1300, Philadelphia, PA 19104
EIN
46-2654405
EDGAR entity type
operating
Insiders and CEO pay
Spark Therapeutics, Inc. on the corporate pages

Offering terms

Proposed price range
$19.00–$21.00 per share (S-1/A filed 2015-01-28)
Final price
$23.00 per share, above the range (424B4 filed 2015-01-30, an initial public offering)
Shares sold
7,000,000
Gross proceeds
$161,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ONCE
Lead underwriters
J.P. Morgan; Credit Suisse
Syndicate
Cowen; Sanford C. Bernstein

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 11

FiledFormWhat it isName as filedEDGAR
2014-12-30S-1S-1 (registration)Spark Therapeutics, Inc.0001193125-14-457223 ↗
2015-01-20S-1/AS-1/A (amendment)Spark Therapeutics, Inc.0001193125-15-013888 ↗
2015-01-28S-1/AS-1/A (amendment)Spark Therapeutics, Inc.0001193125-15-022513 ↗
2015-01-29S-1MEFS-1MEF (added securities)Spark Therapeutics, Inc.0001193125-15-026236 ↗
2015-01-29EFFECTEFFECT (declared effective)Spark Therapeutics, Inc.9999999995-15-000250 ↗
2015-01-30424B4424B4 (final prospectus)Spark Therapeutics, Inc.0001193125-15-026535 ↗
2015-11-25S-1S-1 (registration)Spark Therapeutics, Inc.0001193125-15-388870 ↗
2015-12-14S-1/AS-1/A (amendment)Spark Therapeutics, Inc.0001193125-15-402568 ↗
2015-12-15EFFECTEFFECT (declared effective)Spark Therapeutics, Inc.9999999995-15-003293 ↗
2015-12-16424B1424B1 (final prospectus)Spark Therapeutics, Inc.0001193125-15-404834 ↗
2016-06-22EFFECTEFFECT (declared effective)Spark Therapeutics, Inc.9999999995-16-004976 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2015-01-28S-1/Aregistration statement$19.00–$21.006,500,000-Nasdaq ONCE4primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4document ↗
2015-01-30424B4final prospectus$23.007,000,000$161,000,000Nasdaq ONCE4primary document; price sentence, shares headline, proceeds table, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
AKKARAJU SRINIVASTenPercentOwner12015
Altschuler StevenDirector; Director,TenPercentOwner82015–2019
Betz Alert LorrisDirector42015–2017
Children's Hospital of Philadelphia FoundationDirector,TenPercentOwner; TenPercentOwner112015–2019
Ekman LarsDirector62015–2019
HEALY JAMESTenPercentOwner12015
High Katherine ADirector,OfficerSee Remarks302015–2019person page Fuzzy
Marrazzo Jeffrey DDirector,OfficerChief Executive Officer; CHIEF EXECUTIVE OFFICER292015–2019
Mehra AnandDirector; Director,TenPercentOwner262015–2019
MILANO VINCENTDirector62015–2019
POWELL MICHAELTenPercentOwner12015
SIGAL ELLIOTDirector82015–2019
Sofinnova Management VIII, L.L.C.TenPercentOwner12015
Sofinnova Venture Partners VIII, L.P.TenPercentOwner12015
Vivaldi Coelho RogerioOfficerChief Commercial Officer72015–2016
Webster Stephen WOfficerChief Financial Officer; CHIEF FINANCIAL OFFICER162015–2019
Zoth Lota S.Director; Director,OfficerCHIEF SCIENTIFIC OFFICER72016–2019
Faga DanielOfficerChief Business Officer152016–2019
La Barge JosephOfficerChief Legal Officer; CHIEF LEGAL OFFICER; General Counsel; See remarks182016–2019
Furey JohnOfficerChief Operating Officer72016–2018
PEREZ ROBERT JDirector62018–2019
Dalton LisaOfficerChief Human Resource Officer; CHIEF HUMAN RESOURCE OFFICER; Head of Human Resources42018–2019
Mingozzi FedericoOfficerChief Scientific Officer; CHIEF SCIENTIFIC OFFICER52018–2019
ROCHE HOLDING LTDTenPercentOwner12019
ROCHE HOLDINGS INCTenPercentOwner12019

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2014-06-06Spark Therapeutics, Inc.Biotechnology$72,800,000$72,800,000281

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationSpark Therapeutics, Inc.PAState business registriesname and state
Business registrationSPARK THERAPEUTICS, INC.PAState business registriesname and state
Plan sponsorSPARK THERAPEUTICS, INC.PAForm 5500 (employee benefit plans)EIN (EXACT)
Political committeeSPARK THERAPEUTICS, INC. PAC (SPARK PAC) (connected to SPARK THERAPEUTICS, INC.)PACampaign finance (FEC)name and state
Federal award recipientSPARK THERAPEUTICS, INC.PAFederal spending (USAspending)name and state
Form D issuerSpark Therapeutics, Inc.PAForm D private offeringsCIK (EXACT)
Lobbying clientSPARK THERAPEUTICSPAFederal lobbying (LDA)name and state
Lobbying clientSPARK THERAPEUTICS, INC.PAFederal lobbying (LDA)name and state
Lobbying clientSPARK THERAPEUTICS, INC.PAFederal lobbying (LDA)name and state
Lobbying clientSPARK THERAPEUTICS, INC.PAFederal lobbying (LDA)name and state
Lobbying clientSPARK THERAPEUTICS, INC.PAFederal lobbying (LDA)name and state
Lobbying registrantSPARK THERAPEUTICS, INC.PAFederal lobbying (LDA)name and state
Paying companySpark Therapeutics, Inc.PAOpen Payments (drug and device company payments)name and state
Patent assigneeSPARK THERAPEUTICS, INC.PAPatents (USPTO)name and state
SEC filerSpark Therapeutics, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerSpark Therapeutics, Inc.PATrademarks (USPTO)name and state
Form 5500 plan sponsorSPARK THERAPEUTICS, INC.EIN (EXACT)
Person pageKatherine A High MdPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), PA first:

More with this interest.

In other datasets, the same topic (Health) in PA:

Interests: Biological Products, (No Diagnostic Substances) · Health